LMOIX
Price
$41.37
Change
-$0.64 (-1.52%)
Updated
Jul 31 closing price
Net Assets
2.25B
VISGX
Price
$78.06
Change
-$1.35 (-1.70%)
Updated
Aug 1 closing price
Net Assets
36.92B
Interact to see
Advertisement

LMOIX vs VISGX

Header iconLMOIX vs VISGX Comparison
Open Charts LMOIX vs VISGXBanner chart's image
ClearBridge Small Cap Growth IS
Price$41.37
Change-$0.64 (-1.52%)
VolumeN/A
Net Assets2.25B
Vanguard Small Cap Growth Index I
Price$78.06
Change-$1.35 (-1.70%)
VolumeN/A
Net Assets36.92B
LMOIX vs VISGX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
LMOIX vs. VISGX commentary
Aug 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LMOIX is a Buy and VISGX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VISGX has more cash in the bank: 36.9B vs. LMOIX (2.25B). VISGX pays higher dividends than LMOIX: VISGX (0.42) vs LMOIX (0.00). LMOIX was incepted earlier than VISGX: LMOIX (17 years) vs VISGX (27 years). LMOIX (0.78) is less costly to investors than VISGX (0.19). LMOIX (22.00) and VISGX (21.00) have comparable annual turnover. VISGX has a lower initial minimum investment than LMOIX: VISGX (3000) vs LMOIX (1000000). VISGX annual gain was more profitable for investors over the last year : 9.45 vs. LMOIX (0.82). VISGX return over 5 years is better than : 36.05 vs. LMOIX (-3.98).
LMOIXVISGXLMOIX / VISGX
Total Expense Ratio0.780.19411%
Annual Report Gross Expense Ratio0.780.19411%
Fund Existence17 years27 years-
Gain YTD5.9252.081285%
Front LoadN/AN/A-
Min. Initial Investment1000000300033,333%
Min. Initial Investment IRAN/AN/A-
Net Assets2.25B36.9B6%
Annual Yield % from dividends0.000.42-
Returns for 1 year0.829.459%
Returns for 3 years7.6430.5125%
Returns for 5 years-3.9836.05-11%
Returns for 10 years39.85117.6834%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PGEIX9.55N/A
N/A
Polen Emerging Markets Growth Inst
MSELX23.00N/A
N/A
Morgan Stanley Inst Emerging Mkts L
LGOAX42.13N/A
N/A
Patient Opportunity A
RAZAX11.33-0.05
-0.44%
Russell Inv Multi-Asset Strat A
NYVCX19.74-0.13
-0.65%
Davis NY Venture C